Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Shares Issued: 2015-2024

Historic Shares Issued for Kura Oncology (KURA) over the last 10 years, with Dec 2024 value amounting to $8.6 million.

  • Kura Oncology's Shares Issued fell 83.06% to $515,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $3.7 million, marking a year-over-year change of. This contributed to the annual value of $8.6 million for FY2024, which is 613.43% up from last year.
  • Per Kura Oncology's latest filing, its Shares Issued stood at $8.6 million for FY2024, which was up 613.43% from $1.2 million recorded in FY2023.
  • Over the past 5 years, Kura Oncology's Shares Issued peaked at $459.3 million during FY2020, and registered a low of $1.2 million during FY2023.
  • For the 3-year period, Kura Oncology's Shares Issued averaged around $4.7 million, with its median value being $4.4 million (2022).
  • In the last 5 years, Kura Oncology's Shares Issued tumbled by 99.04% in 2021 and then spiked by 613.43% in 2024.
  • Over the past 5 years, Kura Oncology's Shares Issued (Yearly) stood at $459.3 million in 2020, then crashed by 99.04% to $4.4 million in 2021, then fell by 0.16% to $4.4 million in 2022, then tumbled by 72.71% to $1.2 million in 2023, then skyrocketed by 613.43% to $8.6 million in 2024.